Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- Part 1 Assessing and utilizing the diagnostic or prognostic power of biomarkers
- Part 2 Biomarkers of kidney disease and dysfunction
- Part 3 Biomarkers of bone disease and dysfunction
- Part 4 Biomarkers of liver disease and dysfunction
- 15 Biomarkers of hepatic disease
- 16 The immunogenetics of metabolic liver disease
- 17 Toxicogenetic markers of liver dysfunction
- 18 Prognosis and management of patients with acute liver failure
- 19 Biomarkers in artificial and bioartificial liver support
- 20 Prognostic markers in liver disease
- 21 Apoptosis: biomarkers and the key role of mitochondria
- 22 Liver regeneration: mechanisms and markers
- 23 Determinants of responses to viruses and self in liver disease
- 24 IL-6-type cytokines and signalling in inflammation
- Part 5 Biomarkers of gastrointestinal disease and dysfunction
- Part 6 Biomarkers in toxicology
- Part 7 Biomarkers of cardiovascular disease and dysfunction
- Part 8 Biomarkers of neurological disease and dysfunction
- Part 9 Biomarkers in transplantation
- Index
23 - Determinants of responses to viruses and self in liver disease
Published online by Cambridge University Press: 20 August 2009
- Frontmatter
- Contents
- List of contributors
- Preface
- Part 1 Assessing and utilizing the diagnostic or prognostic power of biomarkers
- Part 2 Biomarkers of kidney disease and dysfunction
- Part 3 Biomarkers of bone disease and dysfunction
- Part 4 Biomarkers of liver disease and dysfunction
- 15 Biomarkers of hepatic disease
- 16 The immunogenetics of metabolic liver disease
- 17 Toxicogenetic markers of liver dysfunction
- 18 Prognosis and management of patients with acute liver failure
- 19 Biomarkers in artificial and bioartificial liver support
- 20 Prognostic markers in liver disease
- 21 Apoptosis: biomarkers and the key role of mitochondria
- 22 Liver regeneration: mechanisms and markers
- 23 Determinants of responses to viruses and self in liver disease
- 24 IL-6-type cytokines and signalling in inflammation
- Part 5 Biomarkers of gastrointestinal disease and dysfunction
- Part 6 Biomarkers in toxicology
- Part 7 Biomarkers of cardiovascular disease and dysfunction
- Part 8 Biomarkers of neurological disease and dysfunction
- Part 9 Biomarkers in transplantation
- Index
Summary
Induction of autoimmune responses by viral infections
Current concepts
Infections by hepatotropic viruses are suspected as triggers for autoimmune liver diseases. Evidence for this hypothesis is provided by numerous observations of the manifestation of autoimmune hepatitis (AIH) after infections with hepatotropic viruses. The list of viruses which have been suspected to have triggered AIH is long and includes hepatitis A virus, hepatitis B virus, hepatitis C virus (HCV), Epstein–Barr virus, herpes simplex virus (HSV), human herpes virus 6 and the measles virus [1]. These viruses show profound differences in replication, tissue distribution and clinical outcome of infection, yet all may cause inflammation in hepatic tissues and may activate humoral and cellular defence mechanisms. This chapter considers potential markers of the autoimmune response induced by viral infection, the detection of which employs conventional serological and genomic analysis. Several postulates have considered how infections with hepatotropic viruses may trigger autoimmune reactions and three are considered below.
Molecular mimicry
In order to minimize the risk of recognition as nonself by the immune system, it is believed that the sequences of viral proteins evolved to resemble closely domains on host proteins which are protected by tolerance. During an immune response, B cells may be generated which show cross-reactivity towards self-proteins. Also, naive T cells with a potential to bind to peripheral self-peptides presented by major histocompatibility complex (MHC) class I or MHC class II receptors may leave the thymus. Usually, these cells will become anergic by peripheral tolerance mechanisms.
- Type
- Chapter
- Information
- Biomarkers of DiseaseAn Evidence-Based Approach, pp. 244 - 255Publisher: Cambridge University PressPrint publication year: 2002